SITC Archive Library

On October 29, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancer" during a live webinar. The recorded webinar and presentation slides are available below.

Webinar Faculty:

• Moderator: Rita Nanda, MD – University of Chicago (Expert Panel Member)
• Elizabeth A. Mittendorf, MD, PhD – Dana-Farber/Brigham and Women's Cancer Center (Expert Panel Member)
  
• David B. Page, MD– Earle A. Chiles Research Institute (Expert Panel Member)

This webinar discussed:

• When biomarker testing should be used and related considerations
• Recommended immunotherapy regimens for early-stage, advanced and metastatic breast cancer
• Distinguishing pseudoprogression from progression when evaluating patient response to immunotherapy

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org or check out our free CPG mobile app.

This webinar is funded solely by SITC.

**Please note that the on-demand webinar is not available for continuing education credits.

#BreastCancers #PresentationSlides #RecordedWebinar #Clinician #NursePractitioner #Oncologist #PatientAdvocate #Pharmacist #RegisteredNurse #PhysicianAssistant #ClinicalPracticeGuideline #2021​